668. Deputy John Paul Phelan asked the Minister for Health the number of type 1 diabetes patients that were approved to use reimbursed diabetes technology; if he will provide a breakdown on the suppliers; the total costs provided to each supplier for this technology, between the years 2020 to 2024; and if he will make a statement on the matter. [41426/24]

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.